The effects of verapamil on the locomotor-activating properties of corticotropin releasing factor (CRF) in the rat.
CRF was administered to rats following intracerebroventricular administration of the calcium antagonist verapamil. Treatment with verapamil elicited biphasic dose-response effects on rat locomotor activity: doses equimolar to CRF treatment slightly increased CRF-stimulated locomotion, while doses of verapamil ten times greater slightly depressed CRF-stimulated locomotion. These results suggest that CRF-stimulated locomotion, unlike other effects of CRF, is not mediated in a simple way by processes dependent on neuronal calcium influx.